Wallonia-BIOMED — HuMAb-S aureus — CER (Q4027002): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Created claim: summary (P836): Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English) | |||||||||||||||
| Property / summary: Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English) / qualifier | |||||||||||||||
point in time: 17 January 2022
| |||||||||||||||
Revision as of 21:18, 17 January 2022
Project Q4027002 in Belgium
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Wallonia-BIOMED — HuMAb-S aureus — CER |
Project Q4027002 in Belgium |
Statements
615,451.18 Euro
0 references
1,538,627.94 Euro
0 references
40.0 percent
0 references
15 May 2014
0 references
31 December 2023
0 references
CER-Groupe
0 references
50°11'10.64"N, 5°17'59.03"E
0 references
6900
0 references
Développement d'un projet de recherche dans le domaine des anticorps monoclonaux humains à but thérapeutique utilisant le S.aureus comme modèle. (French)
0 references
Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English)
17 January 2022
0 references
Identifiers
WAL-874
0 references